Literature DB >> 15592435

Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation.

J Alfredsson1, H Puthalakath, H Martin, A Strasser, G Nilsson.   

Abstract

Mast cells play critical roles in the regulation of acute and chronic inflammations. Apoptosis is one of the mechanisms that limit and resolve inflammatory responses. Mast cell survival can be controlled by growth factors and activation of the IgE-receptor FcvarepsilonRI. Members of the Bcl-2 protein family are critical regulators of apoptosis and our study provides evidence that the proapoptotic BH3-only family member Bim is essential for growth factor deprivation-induced mast cell apoptosis and that Bim levels increase upon FcvarepsilonRI activation. Bim deficiency or Bcl-2 overexpression delayed or even prevented cytokine withdrawal-induced mast cell apoptosis in culture. The prosurvival protein Bcl-XL and the proapoptotic Bim were both induced upon FcvarepsilonRI activation. These results suggest that Bim and possibly also other BH3-only proteins control growth factor withdrawal-induced mast cell apoptosis and that the fate of mast cells upon FcvarepsilonRI activation depends on the relative levels of pro- and antiapoptotic Bcl-2 family members.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15592435     DOI: 10.1038/sj.cdd.4401537

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  32 in total

1.  A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.

Authors:  Fabio Rabelo Melo; Ida Waern; Elin Rönnberg; Magnus Åbrink; David M Lee; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Boris Turk; Sara Wernersson; Gunnar Pejler
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 2.  Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.

Authors:  Toshiaki Kawakami; Jiro Kitaura
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 3.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

4.  Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage.

Authors:  Laurie B Joseph; Donald R Gerecke; Diane E Heck; Adrienne T Black; Patrick J Sinko; Jessica A Cervelli; Robert P Casillas; Michael C Babin; Debra L Laskin; Jeffrey D Laskin
Journal:  Exp Mol Pathol       Date:  2011-06-13       Impact factor: 3.362

Review 5.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

Review 6.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

7.  Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis.

Authors:  Madeleine Rådinger; Daniel Smrž; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

Review 8.  Life in the balance: how BH3-only proteins induce apoptosis.

Authors:  Simon N Willis; Jerry M Adams
Journal:  Curr Opin Cell Biol       Date:  2005-10-21       Impact factor: 8.382

9.  Coaggregation of FcepsilonRI with FcgammaRIIB Inhibits Degranulation but Not Induction of Bcl-2 Family Members A1 and Bim in Mast Cells.

Authors:  Maria Ekoff; Christine Möller; Zou Xiang; Gunnar Nilsson
Journal:  Allergy Asthma Clin Immunol       Date:  2006-09-15       Impact factor: 3.406

Review 10.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.